These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3675802)

  • 1. The nuclear DNA content of human breast carcinoma. Associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome.
    Berryman IL; Harvey JM; Sterrett GF; Papadimitriou JM
    Anal Quant Cytol Histol; 1987 Oct; 9(5):429-34. PubMed ID: 3675802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.
    Harvey J; de Klerk N; Berryman I; Sterrett G; Byrne M; Papadimitriou J
    Breast Cancer Res Treat; 1987; 9(2):101-9. PubMed ID: 3304476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma.
    Klintenberg C; Wallgren A; Bjelkenkrantz K; Carstenssen J; Humla S; Nordenskjöld B; Skoog L
    Acta Radiol Oncol; 1985; 24(3):253-8. PubMed ID: 2994376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear feulgen DNA content and nuclear size in human breast carcinoma.
    Fosså SD; Marton PF; Knudsen OS; Kaalhus O; Børmer O; Vaage S
    Hum Pathol; 1982 Jul; 13(7):626-30. PubMed ID: 7084938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and survival in breast cancer patients.
    Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
    Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
    Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
    Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors and the pattern of relapse in breast cancer.
    Qazi R; Chuang JL; Drobyski W
    Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impulse cytophotometry and catamnesis in breast neoplasms].
    Krug H; Schönfelder M
    Acta Histochem Suppl; 1984; 30():117-27. PubMed ID: 6425932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of DNA stemline and cell kinetics between primary breast cancer and its lymph node metastasis.
    Chang DB; Yang PC; Chang KJ; Luh KT; Kuo SH
    Anal Quant Cytol Histol; 1993 Feb; 15(1):32-8. PubMed ID: 8385953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
    Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
    Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of estrogen receptor status to DNA ploidy in breast cancer.
    Tsuchiya A; Nihei M; Ando Y; Suzuki S; Kimijima I; Abe R
    Surg Today; 1992; 22(2):105-9. PubMed ID: 1498488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay of DNA content and estrogen receptor status in human breast cancer].
    Chen GJ; Shao YF; Shan Y
    Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
    von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
    Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.